<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2016</study_start_year><data_sharing_plan>IPD Sharing (as of November 2022): No</data_sharing_plan><condition>Metastatic Colorectal Cancer</condition><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Metastatic Colorectal Cancer</disease><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2201736</full_dataset_link><location>Austria</location><location>Switzerland</location><study_start_month>3</study_start_month><repository>ECRIN MDR</repository><study_status>Terminated</study_status></additional><is_claimable>false</is_claimable><name>Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy</name><description>The purpose of this study is to assess whether a structured physical activity program (PA) during palliative chemotherapy improves progression-free survival (PFS) and/or patient-reported outcomes (ESAS-r) in patients with metastatic colorectal cancer.</description><dates><creation>2016-03-15</creation></dates><accession>2201736</accession><cross_references><ClinicalTrials___gov>NCT02597075</ClinicalTrials___gov><EU Clinical Trials Register>2015-003733-10</EU Clinical Trials Register></cross_references></HashMap>